The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing world

Journal of Pharmaceutical Sciences
Kishor M WasanBarbara Campbell


The University of British Columbia (UBC) became the first university in Canada to develop a strategy for enhancing global access to its technologies. UBC's University-Industry Liaison Office, in collaboration with the UBC chapter of Universities Allied for Essential Medicines (UAEM), established a mandate and developed principles that provide the developing world with access to UBC technologies. This commentary will discuss these principles and provide examples of where they have been applied to several UBC technologies.


May 1, 1996·Transactions of the Royal Society of Tropical Medicine and Hygiene·C P ThakurP Olliaro
Oct 8, 1999·Lancet·B L Herwaldt
Aug 2, 2002·The Lancet Infectious Diseases·Philippe J GuerinAnthony D M Bryceson
Nov 29, 2002·The New England Journal of Medicine·Shyam SundarJonathan Berman

❮ Previous
Next ❯


Jun 6, 2013·The Lancet Infectious Diseases·Angela LoyseTihana Bicanic
Feb 8, 2013·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Jason Behrmann
Apr 3, 2010·PLoS Neglected Tropical Diseases·Connie E ChenSandeep P Kishore
Feb 27, 2010·PLoS Neglected Tropical Diseases·Sandeep P KishorePeter J Hotez
Jan 11, 2012·The American Journal of Tropical Medicine and Hygiene·Laura W MusselwhiteEthan Guillen
Feb 20, 2016·Emerging Infectious Diseases·Alistair StoryDennis Falzon
May 28, 2016·The European Respiratory Journal·Dennis FalzonMario C Raviglione

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

PLoS Medicine
Olivia KeiserSwiss HIV Cohort Study (SHCS) and the International Epidemiologic Databases to Evaluate AIDS in Southern Africa (IeDEA-SA)
PLoS Neglected Tropical Diseases
Sandeep P KishorePeter J Hotez
Social Science & Medicine
S Kaewsonthi, A G Harding
© 2021 Meta ULC. All rights reserved